Showing results (991-1000 of 1,396) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|February 19, 2026
Real-World Genomic Landscape of Korean Gastric Cancer: Integrating Biomarker Associations and Clinical Outcomes in Metastatic Gastric CancerSeong-Keun Yoo, Soomin Ahn, Jinha Hwang, et al.JCO Precision Oncology|March 5, 2026
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate CancerYu-Wei Chen, Joanne Xiu, Kelsey Anne Poorman, et al.JCO Precision Oncology|March 2, 2026
Swiss-PO 2025: Advancing Cancer Mutation and Structural Analysis for Precision Oncology With the Latest ReleaseFanny S Krebs, Olivier Michielin, Vincent ZoeteJCO Precision Oncology|June 1, 2023
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-AnalysisMirta Mosca, Nicole Conci, Alessandro Di Federico, et al.JCO Precision Oncology|March 28, 2024
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient PopulationRania Chehade, Sharon Nofech-Mozes, Anna Plotkin, et al.JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.JCO Precision Oncology|March 21, 2024
Identifying Oncology Clinical Trial Candidates Using Artificial Intelligence Predictions of Treatment Change: A Pilot Implementation StudyKenneth L Kehl, Tali Mazor, Pavel Trukhanov, et al.JCO Precision Oncology|March 21, 2024
Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-AnalysisZexi Allan, Sasha Witts, Darren J Wong, et al.JCO Precision Oncology|January 31, 2024
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk NeuroblastomaMohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.JCO Precision Oncology|January 31, 2024
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized TrialElisabetta Petracci, Alessandro Passardi, Annibale Biggeri, et al.Pageof 140